Binding studies showed that five of the monoclonal antibodies that neutralized lethal toxin in the macrophage assay (10G3, 2E7, 10G4, 10D4, and 13D10) did so by inhibiting the binding of lethal factor to the protective antigen fragment bound to cells. Monoclonal antibody ID8, which was also able to neutralize lethal toxin activity after LF was prebound to cell-bound PA, only partially inhibited binding of lethal factor to protective antigen. Monoclonal antibody 3F6 did not inhibit the binding of lethal factor to protective antigen.
A competition-binding ELISA showed that at least four different antigenic regions on lethal factor were recognized by these seven neutralizing hybridomas.%,The anomalous behavior of 3F6 suggests that it may induce a conformatio'al change in lethal factor. Differences in neutralizing activity of monoclonal antibodies were related to their relative affinity, epitope specificity, and the type of assay. Differences in neutralizing activity of monoclonal antibodies were related to their relative affinity, epitope specificity, and -the type of assay. One of the hybridoma clones prepared in this report was previously been used for purification of LF from crude culture supernatant flui'ts by affinity chromatography (15, 20) .
ELISA. The ELISA was as previousl', described (19), except The LDH in cells incubated with toxin alone was < 10% of that of zontrol cells not exposed to toxin.
Binding studies with 125I-LF.
Binding studies with radioiodinated LF were based upon previously reported studies (3) . Hybridoma clones specifically mentioned in this report are listed in Table 2 Lethal toxin in the cell culture assay. In addition, the clone that delayed time-to-death of rats (1D8) also neutralized lethal -oxin in the cell culture assay. Identical results were obtained when MAbs were preincubated with LF (40 ng per ml) and then added to cells with bound PA or PA63 (400 ng per ml).
Again, 3F6 and 3E6 did not neutralize lethal toxin. Only one of these MAbs (1D8) neutralized lethal toxin activity when added to cells to which LF was allowed to bind to PA by sequentially incubating J774A.l cells with PA63 (800 ng per ml) then LF (80 ng per ml) at 4 0 C for 2 h each (Fig. 3) . (Table 5) . Monoclonal antibody 1D8, which was able to neutralize lethal toxin activity in the 'ellular assays even after LF was prebound to cell-bound PA, inhibited the binding of 1 2 5 1-labeled LF to PA bound to cell receptors by 41%. The percent binding inhibition for both 3F6
and 3E6, which did not neutralize in the cellular assays, was 7%.
Several other MAbs (3E3, 5E5, 5C8, 8F2, 9E5, and 9F10) blocked the binding of 1 2 5 1-LF to PA from 21 to 32% (Table 2) . However, these MAbs did not appreciably delay the time-to-death of rats injected with lethal toxin and 1 mg of ascites Ig (range 1-1.75 h) and did not demonstrate neutralization in the macrophage cytolytic assays. Table 5 summarizes the properties of these MAbs. The eight neutralizing MAbs also can be placed into one of three groups based upon the relative affinity measurements (31); high affinity (< 0.2 4g), noderate affinity (a 0.2 to < 1 Mg), and low affinity (> 1 Ag). Affinity measurements give a quantitative estimate of the antibody concentration required to achieve 50% plateau binding (29, 30) . We observed neutralization of lethal toxin by
MAbs of moderate and low affinity. (27) . Since the synergistic binding was nonreciprocal, the cbserved effect was probably due to a conformational change (27) in the LF protein. 
